Search results for "Hyoscine butylbromide"

showing 1 items of 1 documents

Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction

2000

In advanced cancer patients with inoperable bowel obstruction, the administration of antisecretive and antiemetic drugs has proved to be effective in controlling gastrointestinal symptoms caused by bowel obstruction. However, controlled studies concerning the most effective antisecretive drug are lacking. The aim of this randomized controlled study was to determine whether octreotide or hyoscine butylbromide was the more effective antisecretive drug for use in states of inoperable bowel obstruction. Eighteen patients with inoperable bowel obstruction randomly received octreotide 0.3 mg daily (n = 9) or hyoscine butylbromide (HB) 60 mg daily (n = 9) s.c. The following parameters were measure…

Malemedicine.medical_specialtyPalliative careNauseaScopolamineOctreotideMuscarinic AntagonistsOctreotideGastroenterologyHyoscine butylbromideStatistics Nonparametriclaw.inventionGastrointestinal AgentsRandomized controlled triallawInternal medicineNausea and vomitingmedicineHumansProspective StudiesProspective cohort studyNursing (all)2901 Nursing (miscellaneous)AgedCancerAged 80 and overGastrointestinal agentChi-Square Distributionbusiness.industryPalliative CareMiddle Agedmedicine.diseaseBowel obstructionTreatment OutcomeOncologyAbdominal NeoplasmsAnesthesiaVomitingFluid TherapyFemalemedicine.symptombusinessIntestinal Obstructionmedicine.drugBowel obstruction
researchProduct